Arkolith/Insider Trading/HRTX/Form 4

Morgan Adam

DirectorHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Aug 12, 2025
Net Buying
Open-Market Buys
$2.6M
Open-Market Sells
$0
Net Open-Market Flow
$2.6M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2025Buy(P)1.8M$1.50$2.6M8.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 8, 2025Buy(P)70K$15.00$1.1M70K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-002160) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML